United Services Automobile Association Ligand Pharmaceuticals Inc Transaction History

United Services Automobile Association

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$86.25 - $120.16 $1.82 Million - $2.54 Million	-21,098 Closed	0 $0
Q2 2019 Aug 16, 2019	SELL	$107.38 - $129.34 $1.31 Million - $1.58 Million	-12,200 Reduced 36.64%	21,098 $2.41 Million
Q1 2019 May 13, 2019	SELL	$105.93 - $142.47 $4.47 Million - $6.01 Million	-42,177 Reduced 55.88%	33,298 $4.19 Million
Q4 2018 Feb 13, 2019	BUY	$128.36 - $272.13 $5.93 Million - $12.6 Million	46,182 Added 157.66%	75,475 $10.2 Million
Q3 2018 Nov 13, 2018	BUY	$211.18 - $274.49 $1.73 Million - $2.25 Million	8,189 Added 38.8%	29,293 $8.04 Million
Q2 2018 Sep 27, 2018	SELL	$150.77 - $207.98 $277,567 - $382,891	-1,841 Reduced 8.02%	21,104 $4.37 Million
Q2 2018 Aug 10, 2018	SELL	$150.77 - $207.98 $2.05 Million - $2.83 Million	-13,600 Reduced 37.21%	22,945 $223,000
Q1 2018 May 14, 2018	SELL	$138.63 - $182.62 $35,350 - $46,568	-255 Reduced 0.69%	36,545 $6.04 Million
Q4 2017 Feb 14, 2018	BUY	$128.36 - $147.04 $462,096 - $529,344	3,600 Added 10.84%	36,800 $5.04 Million
Q3 2017 Nov 14, 2017	BUY	$120.91 - $137.94 $4.01 Million - $4.58 Million	33,200	33,200 $4.52 Million

257

18.2M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $2.07B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of United Services Automobile Association, based on Form 13F filings with the SEC.

Stay updated on United Services Automobile Association with notifications on news.